On August 12, 2020, in connection with the IPO, Mr. Robert Carey, Dr. Dan Dubin and Dr. Deepa Pakianathan (the “Directors”) were appointed to the board of directors of FS Development Corp. The Directors are independent directors. Effective August 12, 2020, Mr. Carey, Dr. Dubin and Dr. Pakianathan were also appointed to the Board’s (i) Audit Committee, with Mr. Carey serving as chair of the Audit Committee, (ii) Compensation Committee, with Dr. Dubin serving as chair of the Compensation Committee and (iii) Nominating and Corporate Governance Committee, with Dr. Pakianathan serving as chair of the Nominating and Corporate Governance Committee. Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of Drs. Bajaj and Dubin and will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, Class II, consists of Dr. Rome and Mr. Carey and will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consists of Dr. Tananbaum and Dr. Pakianathan and will expire at the Company’s third annual meeting of stockholders.